| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |